HALIFAX, April 2 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,
NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions,
announced today that it is now an approved supplier to the Pan American Health
Organization (PAHO) and has received an initial purchase order for rapid HIV
tests from the Ministry of Health in Belize. The PAHO, headquartered in
Washington, D.C., with 35 member states, is an international public health
agency working with Latin America and Caribbean countries on priority health
issues such as HIV. It also serves as the regional office for the World Health
Organization (WHO) in the Americas.
